Micro-pulse Transscleral Laser Therapy and ‘Topical-plus’ Anaesthesia: Ideal for Glaucoma Management During COVID-19

Bernardi, Enrico; Töteberg‐Harms, Marc

doi:10.17925/usor.2021.15.2.50

Cited by 2 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As MPTLT is a relatively new technology, there is no consensus on anesthesia guidelines. Thus, there have been several reports on local anesthesia practices, including the retrobulbar block [ 3 ], the peribulbar block [ 4 ], and analgosedation with topical anesthesia [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy

Sukkee

Taechajongjintana

Ratanawongphaibul

et al. 2023

JCM

View full text Add to dashboard Cite

Background: This study aimed to assess the pain experienced during micropulse transscleral laser therapy (MPTLT) and overnight thereafter and explore the factors associated with the pain. Methods: This prospective study included 100 eyes of 81 glaucoma patients undergoing MPTLT under retrobulbar anesthesia. All patients were asked to rate both types of pain using a numerical rating scale (NRS). The risk factors were explored using multivariable mixed-effects ordinal logistic regression. Results: The mean (SD) NRS pain score during the procedure was 3.57 (3.41) (range 0–10), which included no, mild, moderate, and severe pain in 30 (30%), 33 (33%), 17 (17%), and 20 (20%) eyes, respectively. The mean (SD) NRS score of overnight pain was 2.99 (2.28) (range 0–9), which included no, mild, moderate, and severe pain in 17 (17%), 59 (59%), 17 (17%), and 7 (7%) eyes, respectively. Twenty-seven (27%) eyes reported worse pain overnight than during the procedure. Increased age, initial intraocular pressure, and pain during the procedure were significantly associated with increased overnight pain (p < 0.05). Conclusions: Up to a fourth of eyes had worse pain after discharge. Older age, initial intraocular pressure, and pain during the procedure were risk factors for higher levels of overnight pain.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy

Sukkee

Taechajongjintana

Ratanawongphaibul

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report

2022

View full text Add to dashboard Cite

Introduction Of the many types of laser cyclophotocoagulation procedures, micropulse cyclophotocoagulation diode is praised as a noninvasive, safe, and effective procedure with few complications. In this case report, we describe a rare complication that, to the best of our knowledge, has not been previously reported. Case report We report on the case of a 66-year-old African man with a history of end-stage primary open-angle glaucoma. One week after undergoing micropulse cyclophotocoagulation diode therapy in both eyes, he developed severe intermediary inflammation in one eye, associated with decreased visual acuity. The intraocular pressure had significantly decreased after the procedure and was well controlled with intraocular-pressure-lowering medications. Slit lamp examination revealed a moderate anterior chamber inflammation, anterior vitritis, and a large inflammatory membrane attached to the posterior surface of the intraocular implant. A vitrectomy was finally performed in the left eye because of the persistent intermediary inflammation despite the use of high doses of topical and subconjunctival corticosteroids. Conclusion Intermediary uveitis is a rare complication after micropulse cyclophotocoagulation diode therapy. To the best of our knowledge, there have been no reports of vitritis after a noncomplicated micropulse cyclophotocoagulation diode in primary open-angle glaucoma.

show abstract

Micro-pulse Transscleral Laser Therapy and ‘Topical-plus’ Anaesthesia: Ideal for Glaucoma Management During COVID-19

Cited by 2 publications

References 42 publications

Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy

Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy

Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report

Contact Info

Product

Resources

About